CRSP is leader in Genomics and this recent pullback is a perfect buying opportunity for new entrants. If our Elliott wave impulse thesis plays out, the next target could be $290. LONG
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
